Company profile
UK company 03397582, incorporated on 3 July 1997.
Leading Global CDMO for Pharma & Biotech | Catalent
Providing CDMO services, delivery technologies and manufacturing solutions to develop pharmaceuticals, biologics and consumer health products.
Company number 03397582
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
PSC02 | Transaction MzU0Nzk5MDEzMGFkaXF6a2N4
Published 28 Sep 2026 14:44
PSC07 | Transaction MzU0Nzk4NzI3NGFkaXF6a2N4
Published 28 Sep 2026 14:30
RESOLUTIONS | Transaction WUY4R0ZKWjFhZGlxemtjeA | Paper/PDF filed
Published 25 Aug 2026 22:57
MA | Transaction MzUzODc1NzI4MGFkaXF6a2N4 | Paper/PDF filed
Published 25 Aug 2026 22:52
AA | Transaction MzUzNzM2NjAxM2FkaXF6a2N4
Published 09 Aug 2026 08:07
CERTNM | Transaction MzUzNzMyMTI4MmFkaXF6a2N4
Published 06 Aug 2026 08:26
AP01 | Transaction MzUzNjY3MDc0MWFkaXF6a2N4
Published 03 Aug 2026 11:15
AP01 | Transaction MzUzNjY2OTM3M2FkaXF6a2N4
Published 03 Aug 2026 11:07
TM01 | Transaction MzUzNjY2NzkwMmFkaXF6a2N4
Published 03 Aug 2026 11:00
TM01 | Transaction MzUzNjY2NzY0MmFkaXF6a2N4
Published 03 Aug 2026 10:58
Company registered at Companies House
1 Jul 2014 to 31 Mar 2018
This project is a collaboration between large UK pharmaceutical companies, academia and technology suppliers to generate a structured approach to designing age-appropriate medicines for children and technology for predicting their quality and performance. Paediatric medicine is currently a "hot-topic" within the pharmaceutical industry and there is a lot ...
1 Sep 2013 to 31 Aug 2015
Awaiting Public Project Summary
1 Jul 2010 to 31 Mar 2011
Awaiting Public Summary
